Recurrent Hypertriglyceridemic Acute Pancreatitis: Risk Stratification, Metabolic Susceptibility, and Secondary Prevention
SMART-MD Journal of Precision Medicine · 2026
DOI: 10.69734/b2mjdg03 ↗Kurz gefasst
Fachartikel in der Zeitschrift SMART-MD Journal of Precision Medicine, 2026. Verfasst von Fanyi Kong und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) is increasingly encountered, particularly among patients with metabolic comorbidities. Management extends beyond triglyceride (TG) lowering during the acute episode: clinicians must confirm etiologic attribution, address reversible drivers, assess individual susceptibility, and initiate a sustainable prevention plan before discharge. Recurrence reflects longitudinal TG burden, metabolic and genetic susceptibility, other pancreatic risk factors, and gaps in follow-up. Unlike acute TG-lowering strategies, which focus on the index hospitalization, secondary prevention requires longitudinal assessment of metabolic exposure, individual susceptibility, and treatment durability. Here we describe our SMART approach, which organizes these tasks as Screen and confirm, Modify triggers, Assess susceptibility, Reduce TG burden, and Track and tailor long-term management.
Zitieren
APA
Kong, F., Li, J., Dong, Y., Li, Y., & Wu, D. (2026). Recurrent Hypertriglyceridemic Acute Pancreatitis: Risk Stratification, Metabolic Susceptibility, and Secondary Prevention. SMART-MD Journal of Precision Medicine. https://doi.org/10.69734/b2mjdg03
Vancouver
Kong F, Li J, Dong Y, Li Y, Wu D. Recurrent Hypertriglyceridemic Acute Pancreatitis: Risk Stratification, Metabolic Susceptibility, and Secondary Prevention. SMART-MD Journal of Precision Medicine. 2026. doi:10.69734/b2mjdg03
BibTeX
@article{Kong2026,
author = {Kong, Fanyi and Li, Jianing and Dong, Yanbin and Li, Yuan and Wu, Dong},
title = {Recurrent Hypertriglyceridemic Acute Pancreatitis: Risk Stratification, Metabolic Susceptibility, and Secondary Prevention},
journal = {SMART-MD Journal of Precision Medicine},
year = {2026},
doi = {10.69734/b2mjdg03}
}
EUVIMED